{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:16:14Z","timestamp":1794564974780,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T00:00:00Z","timestamp":1315612800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s11136-011-0003-8","type":"journal-article","created":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T19:57:16Z","timestamp":1315598236000},"page":"1013-1020","source":"Crossref","is-referenced-by-count":121,"title":["Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration"],"prefix":"10.1007","volume":"21","author":[{"given":"Josephine M.","family":"Norquist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Girman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri","family":"Fehnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"DeMuro-Mercon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Santanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,10]]},"reference":[{"key":"3_CR1","unstructured":"Food and Drug Administration. (2009). Guidance for industry: Patient-reported outcome measures: Use in medical product development of support labeling claims. Federal Register. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf ."},{"issue":"4","key":"3_CR2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1185\/03007990902774765","volume":"24","author":"DE Stull","year":"2009","unstructured":"Stull, D. E., Leidy, N. K., Parasuraman, B., & Chassany, O. (2009). Optimal recall periods for patient-reported outcomes: Challenges and potential solutions. CMRO, 24(4), 929\u2013942.","journal-title":"CMRO"},{"issue":"5","key":"3_CR3","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry, M. J., Fowler, F. J., Oleary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., et al. (1992). The American-Urological-Association symptom index for benign prostatic hyperplasia. Journal of Urology, 148(5), 1549\u20131557.","journal-title":"Journal of Urology"},{"issue":"1","key":"3_CR4","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jpainsymman.2007.04.004","volume":"34","author":"RA Mularski","year":"2007","unstructured":"Mularski, R. A., Rosenfeld, K., Coons, S. J., Dueck, A., Cella, D., Feuer, D., et al. (2007). Measuring outcomes in randomized prospective trials in palliative care. Journal of Pain and Symptom Management Volume, 34(1), S7\u2013S19.","journal-title":"Journal of Pain and Symptom Management Volume"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3322\/CA.57.5.278","volume":"57","author":"J Lipscomb","year":"2007","unstructured":"Lipscomb, J., Gotay, C., & Snyder, C. (2007). Patient-reported outcomes in cancer: A review of recent research and policy initiatives. CA: A Cancer Journal for Clinicians, 57, 278\u2013300.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"3_CR6","unstructured":"National Cancer Institute. (2008). The nation\u2019s investment in cancer research: A plan and budget proposal for fiscal year 2008. NIH Publication No. 06\u20136090. Available at: http:\/\/plan.cancer.gov . Accessed 22 Aug 2008."},{"issue":"4","key":"3_CR7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0090-4295(02)02505-0","volume":"61","author":"JS Brown","year":"2003","unstructured":"Brown, J. S., McNaughton, K. S., Wyman, J. F., Burgio, K. L., Harkaway, R., Bergner, D., et al. (2003). Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology, 61(4), 802\u2013809.","journal-title":"Urology"},{"issue":"1","key":"3_CR8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/13697130701744696","volume":"11","author":"RE Williams","year":"2008","unstructured":"Williams, R. E., Kalilani, L., DiBenedetti, D. B., Zhou, X., Granger, A. L., Fehnel, S. E., et al. (2008). Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric, 11(1), 32\u201343.","journal-title":"Climacteric"},{"issue":"6","key":"3_CR9","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/01.AOG.0000143891.79482.ee","volume":"104","author":"JS Carpenter","year":"2004","unstructured":"Carpenter, J. S., & Monahan, P. O. (2004). Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring. Obstetrics and Gynecology, 104(6), 1322\u20131326.","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"3_CR10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","volume":"231","author":"Coronary Drug Project Group","year":"1975","unstructured":"Coronary Drug Project Group. (1975). Clofibrate and niacin in coronary heart disease. Jama, 231(4), 360\u2013381.","journal-title":"Jama"},{"issue":"1","key":"3_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1378\/chest.125.1.93","volume":"125","author":"EF Juniper","year":"2004","unstructured":"Juniper, E. F., Svensson, K., M\u00f6rk, A. C., & St\u00e5hl, E. (2004). Measuring health-related quality of life in adults during an acute asthma exacerbation. Chest, 125(1), 93\u201397.","journal-title":"Chest"},{"key":"3_CR12","unstructured":"Furlong, W. B., Feeny, D., & Yandow, S. (2005). Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: A case study in measurement selection. Health and Quality of Life Outcomes, (3), 1477\u20137525."},{"issue":"12","key":"3_CR13","first-page":"1833","volume":"15","author":"N Bellamy","year":"1988","unstructured":"Bellamy, N., Buchanan, W. W., Goldsmith, C. H., Campbell, J., & Stitt, L. W. (1988). Validation-study of WOMAC: A health-status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug-therapy in patients with osteo-arthritis of the hip or knee. Journal of Rheumatology, 15(12), 1833\u20131840.","journal-title":"Journal of Rheumatology"},{"issue":"14","key":"3_CR14","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.161.14.1733","volume":"161","author":"M Camilleri","year":"2001","unstructured":"Camilleri, M., Chey, W. Y., Mayer, E. A., Northcutt, A. R., Heath, A., Dukes, G. E., et al. (2001). A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Archives of Internal Medicine, 161(14), 1733\u20131740.","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"3_CR15","first-page":"A94","volume":"128","author":"S Leventer","year":"2005","unstructured":"Leventer, S., Raudibaugh, K., Frissora, C., Mangel, A., Galbraith, K. B., Kucharik, R., et al. (2005). The safety and efficacy of dextofisopam in patients with diarrhea-predominant or alternating irritable bowel syndrome. Gastroenterology, 128(4), A94.","journal-title":"Gastroenterology"},{"issue":"2","key":"3_CR16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/00365520310006748","volume":"39","author":"H Nyhlin","year":"2004","unstructured":"Nyhlin, H., Bang, C., Elsborg, L., Silvennoinen, J., Holme, I., Ruegg, P., et al. (2004). A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome. Scandinavian Journal of Gastroenterology, 39(2), 119\u2013126.","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"10","key":"3_CR17","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.14309\/00000434-200410001-00846","volume":"99","author":"P Miner","year":"2004","unstructured":"Miner, P., Stanton, D. B., Carter, F., Caras, S., Krause, G., & Steinborn, C. (2004). Cilansetron in irritable bowel syndrome with diarrhea predominance (IBS-D): Efficacy and safety in a 3\u00a0months US study. American Journal of Gastroenterology, 99(10), S277.","journal-title":"American Journal of Gastroenterology"},{"key":"3_CR18","doi-asserted-by":"crossref","unstructured":"Fehnel, S., Johnston, J., Kurtz, C., & Mangel, A. (2006). Assessing global change and symptom severity in subjects with IBS: Qualitative item testing. American Journal of Gastroenterology, 101, S483.","DOI":"10.14309\/00000434-200609001-01248"},{"issue":"5","key":"3_CR19","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1053\/j.gastro.2005.11.058","volume":"130","author":"EJ Irvine","year":"2006","unstructured":"Irvine, E. J., Whitehead, W. E., Chey, W. D., Matsueda, K., Shaw, M., Talley, N. J., et al. (2006). Design of treatment trials for functional gastrointestinal disorders. Gastroenterology, 130(5), 1538\u20131551.","journal-title":"Gastroenterology"},{"issue":"4","key":"3_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1008974420049","volume":"8","author":"DP Lubeck","year":"1999","unstructured":"Lubeck, D. P., Prebil, L. A., Peeples, P., & Brown, J. S. (1999). A health related quality of life measure for use in patients with urge urinary incontinence: A validation study. Quality of Life Research, 8(4), 337\u2013344.","journal-title":"Quality of Life Research"},{"issue":"4","key":"3_CR21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1023422208910","volume":"12","author":"PR Reese","year":"2003","unstructured":"Reese, P. R., Pleil, A. M., Okano, G. J., & Kelleher, C. J. (2003). Multinational study of reliability and validity of the King\u2019s Health Questionnaire in patients with overactive bladder. Quality of Life Research, 12(4), 427\u2013442.","journal-title":"Quality of Life Research"},{"key":"3_CR22","unstructured":"Feinstein, R. P. (2007). Androgenetic Alopecia. EMedicine (from WebMD)."},{"issue":"3","key":"3_CR23","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1067\/mjd.2001.117631","volume":"45","author":"EA Olsen","year":"2001","unstructured":"Olsen, E. A. (2001). Female pattern hair loss: Clinical features and potential hormonal factors. Journal of the American Academy of Dermatology, 45(3), S69.","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"3_CR24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","volume":"50","author":"AW Lucky","year":"2004","unstructured":"Lucky, A. W., Piacquadio, D. J., Ditre, C. M., Dunlap, F., Kantor, I., Pandya, A. G., et al. (2004). A randomized, placebo-controlled trial of 5 and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Journal of the American Academy of Dermatology, 50(4), 541\u2013553.","journal-title":"Journal of the American Academy of Dermatology"},{"key":"3_CR25","doi-asserted-by":"crossref","unstructured":"Revicki, D. A., Camilleri, M., Kuo, B., Norton, J. N., Murray, L., Palsgrove, A., & Parkman, H. P. (2009). Development and content validity of a gastroparesis cardinal symptom index daily diary. Alimentary Pharmacology & Therapeutics, 30(6), 670\u2013680.","DOI":"10.1111\/j.1365-2036.2009.04078.x"},{"key":"3_CR26","doi-asserted-by":"crossref","unstructured":"Revicki, D. A., Margolis, M. K., Bush, E. N., DeRogatis, L. R., & Hanes, V. (2011). Content validity of the female sexual function index (FSFI) in pre- and postmenopausal women with hypoactive sexual desire disorder. Journal of Sexual Medicine (Epub ahead of print).","DOI":"10.1111\/j.1743-6109.2011.02312.x"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-011-0003-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-011-0003-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-011-0003-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T13:13:37Z","timestamp":1592918017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-011-0003-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,10]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s11136-011-0003-8","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,10]]}}}